Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
ANAB compared with TRAX: revenue, margins and what each company keeps, and the suppliers and customers both name
ANAB
Anaptysbio, Inc
Change
Mkt cap
Revenue
Revenue
TRAX
First Tracks Biotherapeutics, Inc.
Change
Mkt cap
Revenue
Revenue
vs
Compare
ANAB
Anaptysbio, Inc
vs
TRAX
First Tracks Biotherapeutics, Inc.
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Price
Desk
News
Calendar
Saved
Search
Price
rebased to 0%
1D
1W
1M
3M
YTD
1Y
5Y
1D
1W
1M
3M
YTD
1Y
5Y
ANAB, solid
TRAX, dashed
ANAB
Anaptysbio, Inc
Change
48.04
▼
−0.51%
· post 47.31
· delayed
Mkt cap
$1.4B
Revenue
$26M
Q1 FY26
Revenue
$235M
FY25
TRAX
First Tracks Biotherapeutics, Inc.
Change
44.94
▼
−0.32%
· post 44.94
· delayed
After hours
Nov 2 '26
delayed
Mkt cap
$1.6B
Revenue
—
Revenue
—
vs
Compare
After hours
Nov 2 '26
delayed
ANAB
Anaptysbio, Inc
vs
TRAX
First Tracks Biotherapeutics, Inc.
48.04
▼
−0.51%
post 47.31
delayed
Price
44.94
▼
−0.32%
post 44.94
delayed
$1.4B
Mkt cap
$1.6B
Q1 FY26
$26M
Revenue
—
FY25
$235M
Revenue
—
Change
Change
ANAB
48.04
▼
−0.51%
vs
TRAX
44.94
▼
−0.32%
After hours
Nov 2 '26
delayed